CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 3

Incompliant submissions 0

Total trials 3

My Organizations' Clinical Trials

Showing 25 of 55 entries

View as:

Preventing Acute Chest Syndrome by Transfusion Feasibility Study

Phase: N/A Priority: Normal

NCT ID: NCT00951808 Org: User:

Start: 07/31/09 End: 07/31/10 Due: 07/31/11

Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)

Phase: N/A Priority: Normal

NCT ID: NCT00502788 Org: User:

Start: 05/31/03 End: 08/31/06 Due: 08/31/07

Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children

Phase: N/A Priority: Normal

NCT ID: NCT05287412 Org: User:

Start: 09/30/20 End: 12/31/25 Due: 12/31/26

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00429364 Org: User:

Start: 01/31/07 End: 02/28/14 Due: 02/28/15

Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions

Phase: N/A Priority: Normal

NCT ID: NCT00872833 Org: User:

Start: 07/31/09 End: 10/31/10 Due: 10/31/11

Single Ventricle Reconstruction Extension Study (SVR II) - Pediatric Heart Network

Phase: N/A Priority: Normal

NCT ID: NCT02110823 Org: User:

Start: 03/31/08 End: 06/30/25 Due: 06/30/26

Training in Exercise Activities and Motion for Growth

Phase: N/A Priority: Normal

NCT ID: NCT01917084 Org: User:

Start: 06/30/13 End: 12/31/14 Due: 12/31/15

Optimal Platelet Dose Strategy for Management of Thrombocytopenia

Phase: N/A Priority: Normal

NCT ID: NCT00128713 Org: User:

Start: 07/31/04 End: 01/31/08 Due: 01/31/09

Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence

Phase: N/A Priority: Normal

NCT ID: NCT00064662 Org: User:

Start: 02/28/02 End: 03/31/10 Due: 03/31/11

Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00872170 Org: User:

Start: 03/31/09 End: 11/30/10 Due: 11/30/11

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

Phase: N/A Priority: Normal

NCT ID: NCT01912534 Org: User:

Start: 03/31/14 End: 07/31/19 Due: 07/31/20

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Phase: N/A Priority: Normal

NCT ID: NCT00115349 Org: User:

Start: 06/30/05 End: 04/30/09 Due: 04/30/10

Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network

Phase: N/A Priority: Normal

NCT ID: NCT00123071 Org: User:

Start: 05/31/05 End: 06/30/09 Due: 06/30/10

Assessment of Pain in People With Thalassemia

Phase: N/A Priority: Normal

NCT ID: NCT00872339 Org: User:

Start: 03/31/09 End: 12/31/10 Due: 12/31/11

The Children's Amalgam Trial

Phase: N/A Priority: Normal

NCT ID: NCT00065988 Org: User:

Start: 09/30/97 End: 03/31/05 Due: 03/31/06

Value of Urodynamic Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT00803959 Org: User:

Start: 11/30/08 End: 06/30/10 Due: 06/30/11

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Phase: N/A Priority: Normal

NCT ID: NCT04702373 Org: User:

Start: 02/23/21 End: 12/30/24 Due: 12/30/25

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Phase: N/A Priority: Normal

NCT ID: NCT02381509 Org: User:

Start: 10/31/15 End: 09/20/21 Due: 09/20/22

Rituximab to Treat Severe Hemophilia A

Phase: N/A Priority: Normal

NCT ID: NCT00331006 Org: User:

Start: 06/30/06 End: 01/31/12 Due: 01/31/13

Use of Oxandrolone to Promote Growth in Infants With HLHS

Phase: N/A Priority: Normal

NCT ID: NCT04090697 Org: User:

Start: 12/20/19 End: 09/19/23 Due: 09/19/24

A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics

Phase: N/A Priority: Normal

NCT ID: NCT01915277 Org: User:

Start: 04/02/14 End: 10/17/17 Due: 10/17/18

Red Cell Storage Duration Study

Phase: N/A Priority: Normal

NCT ID: NCT00991341 Org: User:

Start: 01/31/10 End: 03/31/14 Due: 03/31/15

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

Phase: N/A Priority: Normal

NCT ID: NCT00094302 Org: User:

Start: 08/31/06 End: 06/30/13 Due: 06/30/14

A Pilot Study of Biomarkers for Spinal Muscular Atrophy

Phase: N/A Priority: Normal

NCT ID: NCT00756821 Org: User:

Start: 10/31/08 End: 03/31/09 Due: 03/31/10

Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type

Phase: N/A Priority: Normal

NCT ID: NCT02455531 Org: User:

Start: 06/30/15 End: 06/30/25 Due: 06/30/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Preventing Acute Chest Syndrome by Transfusion Feasibility Study	NCT00951808	Carelon Research	user2@example.com	None	2009-07-31	2010-07-31	2011-07-31	-	-	2025-07-14
Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)	NCT00502788	Carelon Research	user2@example.com	None	2003-05-31	2006-08-31	2007-08-31	-	-	2025-07-14
Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children	NCT05287412	Carelon Research	user2@example.com	None	2020-09-30	2025-12-31	2026-12-31	-	-	2025-07-14
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome	NCT00429364	Carelon Research	user2@example.com	None	2007-01-31	2014-02-28	2015-02-28	-	-	2025-07-14
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions	NCT00872833	Carelon Research	user2@example.com	None	2009-07-31	2010-10-31	2011-10-31	-	-	2025-07-14
Single Ventricle Reconstruction Extension Study (SVR II) - Pediatric Heart Network	NCT02110823	Carelon Research	user2@example.com	None	2008-03-31	2025-06-30	2026-06-30	-	-	2025-07-14
Training in Exercise Activities and Motion for Growth	NCT01917084	Carelon Research	user2@example.com	None	2013-06-30	2014-12-31	2015-12-31	-	-	2025-07-14
Optimal Platelet Dose Strategy for Management of Thrombocytopenia	NCT00128713	Carelon Research	user2@example.com	None	2004-07-31	2008-01-31	2009-01-31	-	-	2025-07-14
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence	NCT00064662	Carelon Research	user2@example.com	None	2002-02-28	2010-03-31	2011-03-31	-	-	2025-07-14
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension	NCT00872170	Carelon Research	user2@example.com	None	2009-03-31	2010-11-30	2011-11-30	-	-	2025-07-14
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM	NCT01912534	Carelon Research	user2@example.com	None	2014-03-31	2019-07-31	2020-07-31	-	-	2025-07-14
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases	NCT00115349	Carelon Research	user2@example.com	None	2005-06-30	2009-04-30	2010-04-30	-	-	2025-07-14
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network	NCT00123071	Carelon Research	user2@example.com	None	2005-05-31	2009-06-30	2010-06-30	-	-	2025-07-14
Assessment of Pain in People With Thalassemia	NCT00872339	Carelon Research	user2@example.com	None	2009-03-31	2010-12-31	2011-12-31	-	-	2025-07-14
The Children's Amalgam Trial	NCT00065988	Carelon Research	user2@example.com	None	1997-09-30	2005-03-31	2006-03-31	-	-	2025-07-14
Value of Urodynamic Evaluation	NCT00803959	Carelon Research	user2@example.com	None	2008-11-30	2010-06-30	2011-06-30	-	-	2025-07-14
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT	NCT04702373	Carelon Research	user2@example.com	None	2021-02-23	2024-12-30	2025-12-30	-	-	2025-07-14
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters	NCT02381509	Carelon Research	user2@example.com	None	2015-10-31	2021-09-20	2022-09-20	-	-	2025-07-14
Rituximab to Treat Severe Hemophilia A	NCT00331006	Carelon Research	user2@example.com	None	2006-06-30	2012-01-31	2013-01-31	-	-	2025-07-14
Use of Oxandrolone to Promote Growth in Infants With HLHS	NCT04090697	Carelon Research	user2@example.com	None	2019-12-20	2023-09-19	2024-09-19	-	-	2025-07-14
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics	NCT01915277	Carelon Research	user2@example.com	None	2014-04-02	2017-10-17	2018-10-17	-	-	2025-07-14
Red Cell Storage Duration Study	NCT00991341	Carelon Research	user2@example.com	None	2010-01-31	2014-03-31	2015-03-31	-	-	2025-07-14
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function	NCT00094302	Carelon Research	user2@example.com	None	2006-08-31	2013-06-30	2014-06-30	-	-	2025-07-14
A Pilot Study of Biomarkers for Spinal Muscular Atrophy	NCT00756821	Carelon Research	user2@example.com	None	2008-10-31	2009-03-31	2010-03-31	-	-	2025-07-14
Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type	NCT02455531	Carelon Research	user2@example.com	None	2015-06-30	2025-06-30	2026-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance